Skip to Content

The originating document has been archived. We cannot confirm the completeness, accuracy and currency of the content.


In the US, Anistreplase is a member of the drug class thrombolytics and is used to treat Heart Attack.



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Therapeutic Category

Anticoagulant agent: Fibrinolytic

Chemical Name

Plasminogen-Streptokinase-4-Amidinophenyl p-anisat hydrochlorid (1:1:1)

Foreign Names

  • Anistreplasum (Latin)
  • Anistreplase (German)
  • Anistreplase (French)
  • Anistreplasa (Spanish)

Generic Names

  • Anistreplase (OS: BAN, DCF, USAN)
  • APSAC (IS)
  • BRL 26921 (IS)

Brand Name


BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.